Agent-based modelling of Mycobacterium tuberculosis transmission: a systematic review.

Publication date: Dec 06, 2024

Traditional epidemiological models tend to oversimplify the transmission dynamics of Mycobacterium tuberculosis (M. tb) to replicate observed tuberculosis (TB) epidemic patterns. This has led to growing interest in advanced methodologies like agent-based modelling (ABM), which can more accurately represent the complex heterogeneity of TB transmission. To better understand the use of agent-based models (ABMs) in this context, we conducted a systematic review with two main objectives: (1) to examine how ABMs have been employed to model the intricate heterogeneity of M. tb transmission, and (2) to identify the challenges and opportunities associated with implementing ABMs for M. tb. We conducted a systematic search following PRISMA guidelines across four databases (MEDLINE, EMBASE, Global Health, and Scopus), limiting our review to peer-reviewed articles published in English up to December 2022. Data were extracted by two investigators using a standardized extraction tool. Prospero registration: CRD42022380580. Our review included peer-reviewed articles in English that implement agent-based, individual-based, or microsimulation models of M. tb transmission. Models focusing solely on in-vitro or within-host dynamics were excluded. Data extraction targeted the methodological, epidemiological, and computational characteristics of ABMs used for TB transmission. A risk of bias assessment was not conducted as the review synthesized modelling studies without pooling epidemiological data. Our search initially identified 5,077 studies, from which we ultimately included 26 in our final review after exclusions. These studies varied in population settings, time horizons, and model complexity. While many incorporated population heterogeneity and household structures, some lacked essential features like spatial structures or economic evaluations. Only eight studies provided publicly accessible code, highlighting the need for improved transparency. ABMs are a versatile approach for representing complex disease dynamics, particularly in cases like TB, where they address heterogeneous mixing and household transmission often overlooked by traditional models. However, their advanced capabilities come with challenges, including those arising from their stochastic nature, such as parameter tuning and high computational expense. To improve transparency and reproducibility, open-source code sharing, and standardised reporting are recommended to enhance ABM reliability in studying epidemiologically complex diseases like TB.

Open Access PDF

Concepts Keywords
Crd42022380580 Agent-based modelling
English Epidemiological Models
Mycobacterium Humans
Pooling Mycobacterium tuberculosis
Tuberculosis Mycobacterium tuberculosis
Systems Analysis
Transmission
Tuberculosis
Tuberculosis

Semantics

Type Source Name
disease MESH tuberculosis
pathway KEGG Tuberculosis
drug DRUGBANK Tropicamide
disease IDO host
disease MESH Infectious Diseases
pathway REACTOME Reproduction
drug DRUGBANK Pumactant
disease MESH influenza
disease MESH malaria
pathway KEGG Malaria
disease MESH COVID 19
disease MESH pus
drug DRUGBANK Methionine
drug DRUGBANK Indoleacetic acid
disease IDO contact tracing
disease MESH latent infection
drug DRUGBANK Dimercaprol
disease IDO country
disease IDO history
disease IDO pathogen
disease MESH infection
disease IDO algorithm
drug DRUGBANK Gold
disease MESH latent tuberculosis infection
disease MESH comorbidity
disease IDO quality
disease MESH uncertainty
drug DRUGBANK Flunarizine
drug DRUGBANK Ademetionine
disease IDO intervention
drug DRUGBANK Ranitidine
disease IDO replication
drug DRUGBANK Vildagliptin
drug DRUGBANK Coenzyme M
disease IDO immunodeficiency
drug DRUGBANK Honey
disease MESH emergency
disease MESH diabetes mellitus
drug DRUGBANK Serine

Original Article

Leave a Comment

Your email address will not be published. Required fields are marked *